Analysts/Institutional Investor Meet/Con. Call Updates

November 06, 2026 To, To, The Listing Department, The Listing Department BSE Limited, National Stock Exchange of India Ltd., Phiroze Jeejeebhoy Towers, Exchange Plaza, Bandra Kurla Complex, Dalal Street, Mumbai – 400001 Bandra (East), Mumbai – 400051 Scrip code: 544889 Symbol: SYMBIOTEC Dear Sir/ Ma'am, Sub: Audio recording of earnings conference call for Analysts and Investors Ref: Disclosure under Part A of Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 Pursuant to Part A of Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the Audio recording of Conference Call for Analysts and Investors held on November 06, 2026, is available on the website of the Company, the link of the same is stated herein- below: https://investor.symbiotec.com/financials?tab=transcripts You are requested to kindly take the same in your records. Thanking You. Sincerely, For Symbiotec Pharmalab Limited Salil Jain Company Secretary and Compliance Officer Membership No. A41610 Registered Office & Works: Symbiotec Pharmalab Limited (Formerly known as Symbiotec Pharmalab Pvt. Ltd.) 385/2, Pigdamber, Rau, Mhow, Indore - 453331, Madhya Pradesh, India Tel. No.: +91-731-6676405-406 Fax: +91-731-4201222, Email ID : symbiotec@symbiotec.com, Website : www.symbiotec.com CIN: U24232MP2002PLC015293